Q: What are your thoughts on this news?
Knight Therapeutics (TSX:GUD) has struck a deal with Puma Biotech (NASDAQ:PBYI) to commercialize breast cancer treatment NERLYNX in Canada.
Knight Therapeutics (TSX:GUD) has struck a deal with Puma Biotech (NASDAQ:PBYI) to commercialize breast cancer treatment NERLYNX in Canada.